A phase 2 randomized study of SHAPE Gel (SHP-141) in patients with early-stage cutaneous T-cell lymphoma: Interim results. Duvic, M., Kim, Y. H., LeBoeuf, N. R., Porcu, P., Hastings, J., Bassuner, J., Sowerby, L., Posligua-Alban, A., Guitart, J. AMER SOC CLINICAL ONCOLOGY. 2016

View details for DOI 10.1200/JCO.2016.34.15_suppl.7562

View details for Web of Science ID 000404711505075